Table 5. Adverse events by treatment arm.
| Adverse events (n = 358) | Total | Chloroquine | Artemether-lumefantrine | Chloroquine plus primaquine | Artemether-lumefantrine plus primaquine | p-Value |
|---|---|---|---|---|---|---|
| Headache | 91 (25.5%) | 27 (29.7%) | 29 (31.9%) | 19 (20.9%) | 16 (17.6%) | 0.68 |
| Fever | 67 (18.8%) | 13 (19.4%) | 18 (26.9%) | 16 (23.9%) | 20 (29.9%) | 0.16 |
| Chills | 33 (9.2%) | 11 (33.3%) | 12 (36.4%) | 5 (15.2%) | 5 (15.2%) | 0.43 |
| Cough | 25 (7.0%) | 8 (32.0%) | 5 (20.0%) | 8 (32.0%) | 4 (16.0%) | 0.53 |
| Vomiting | 24 (6.7%) | 7 (29.2%) | 5 (20.8%) | 7 (29.2%) | 5 (20.8%) | 0.79 |
| Body pain | 18 (5.0%) | 3 (16.7%) | 6 (3.3%) | 5 (27.8%) | 4 (22.2%) | 0.77 |
| Abdominal pain | 17 (4.8%) | 7 (41.2%) | 3 (17.6%) | 4 (23.5%) | 3 (17.6%) | 0.55 |
| Weakness | 15 (4.2%) | 5 (33.3%) | 5 (33.3%) | 4 (26.7%) | 1 (6.7%) | 0.59 |
| Diarrhoea | 15 (4.0%) | 4 (26.7%) | 3 (20.0%) | 4 (26.7%) | 4 (26.7%) | 0.86 |
| Fever and headache | 13 (3.6%) | 1 (7.7%) | 5 (38.5%) | 2 (15.4%) | 5 (38.5%) | 0.20 |
| Nausea | 12 (3.4%) | 4 (33.3%) | 5 (41.7%) | 1 (8.3%) | 2 (16.7%) | 0.54 |
Data are given as n (percent).